MML Investors Services
MRNA icon

MML Investors Services’s Moderna MRNA Stock Holding History

MML Investors Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$473K Buy
6,761
+888
+15% +$45.9K ﹤0.01% 2501
2026
Q1 		$298K Buy
+5,873
New +$274K ﹤0.01% 2563
2025
Q2 		– Sell
-9,605
Closed -$272K – 2853
2025
Q1 		$272K Sell
9,605
-25,965
-73% -$921K ﹤0.01% 2364
2024
Q4 		$1.48M Buy
35,570
+1,675
+5% +$80.1K 0.01% 1289
2024
Q3 		$2.27M Buy
33,895
+6,018
+22% +$553K 0.01% 1028
2024
Q2 		$3.31M Buy
27,877
+1,586
+6% +$201K 0.01% 804
2024
Q1 		$2.8M Sell
26,291
-10,115
-28% -$1.02M 0.01% 895
2023
Q4 		$3.62M Buy
36,406
+7,684
+27% +$646K 0.02% 735
2023
Q3 		$2.97M Buy
28,722
+3,281
+13% +$366K 0.02% 735
2023
Q2 		$3.09M Buy
25,441
+2,123
+9% +$283K 0.02% 716
2023
Q1 		$3.58M Sell
23,318
-2,641
-10% -$436K 0.03% 570
2022
Q4 		$4.66M Sell
25,959
-1,484
-5% -$243K 0.03% 509
2022
Q3 		$3.25M Buy
27,443
+799
+3% +$121K 0.02% 577
2022
Q2 		$3.81M Buy
26,644
+2,367
+10% +$338K 0.03% 508
2022
Q1 		$4.18M Buy
24,277
+14,383
+145% +$2.42M 0.03% 498
2021
Q4 		$2.51M Sell
9,894
-7,874
-44% -$2.3M 0.02% 673
2021
Q3 		$6.84M Buy
17,768
+2,427
+16% +$895K 0.05% 333
2021
Q2 		$3.6M Buy
15,341
+2,000
+15% +$357K 0.03% 494
2021
Q1 		$1.75M Buy
13,341
+2,912
+28% +$422K 0.02% 702
2020
Q4 		$1.09M Buy
10,429
+843
+9% +$85.3K 0.01% 798
2020
Q3 		$678K Buy
9,586
+2,957
+45% +$206K 0.01% 921
2020
Q2 		$426K Sell
6,629
-991
-13% -$54.3K 0.01% 1064
2020
Q1 		$228K Buy
+7,620
New +$175K ﹤0.01% 1211

Other funds holding MRNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services's MRNA Position: Q2 2026 in Review

MML Investors Services increased its Moderna (MRNA) stake by 15% in Q2 2026, buying an estimated $45.9K and bringing the position to 6,761 shares worth $473K. The position accounts for ﹤0.01% of the portfolio, ranked #2501.

MML Investors Services first reported a position in MRNA in Q1 2020 and has held it in 23 quarters since. The position peaked at $6.84M in Q3 2021. 612 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • MML Investors Services held 6,761 shares of Moderna worth $473K as of Q2 2026.
  • MML Investors Services bought 888 Moderna shares in Q2 2026, an estimated $45.9K.
  • Moderna made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2501 holding.
  • MML Investors Services first reported a position in Moderna in Q1 2020 and has held it in 23 quarters since.
  • MML Investors Services's Moderna position peaked at $6.84M in Q3 2021.
  • 612 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.